Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q17113918> ?p ?o }
Showing triples 1 to 58 of
58
with 100 triples per page.
- Q17113918 subject Q6353443.
- Q17113918 abstract "MOLMED is a medical biotechnology company located in Milan, inside the San Raffaele Biomedical Science Park(which houses the San Raffaele research hospital and Scientific Institute, and a private university). The company was founded by Claudio Bordignonin 1996 as a joint venture between Science Park Raf and Boehringer Mannheim, in order to create a cGMP structure specialised in the ex vivo manipulation of human cells for supplying gene and cell therapy services for clinical trial protocols.MolMed activities cover all functions, from discovery to proof of clinical activity, focuses on oncology indications that require new therapy options and has an in-house GMP-based manufacturing of cell and gene therapy products.MolMed's product portfolio contains two therapeutic antitumour drugs undergoing clinical trial: TK cell therapy product that permits bone marrow transplant from donors that are partially compatible with the patient, in Phase III for the treatment of high-risk leukaemia;NGR-hTNF (antitumor recombinant protein), a recombinant biological drug that targets tumour blood vessels, in Phase III in malignant pleural mesothelioma and in Phase II in six other indications: colorectal, liver and ovarian cancers, small-cell lung cancer, non-small cell lung cancer and in soft-tissue sarcomas.MolMed also provides high-level competencies in gene and cell therapy for the development, performance and validation of projects for third parties; said competencies range from preclinical studies to Phase III clinical trials, including the production in compliance with current GMP of viral vectors and patient-specific genetically modified cells for clinical use.".
- Q17113918 foundingYear "1996".
- Q17113918 industry Q7108.
- Q17113918 keyPerson Q140686.
- Q17113918 keyPerson Q3679953.
- Q17113918 keyPerson Q484876.
- Q17113918 location Q38.
- Q17113918 location Q490.
- Q17113918 numberOfEmployees "1202013".
- Q17113918 operatingIncome "18.169".
- Q17113918 product Q17143177.
- Q17113918 product Q17637123.
- Q17113918 revenue "6.714".
- Q17113918 type Q891723.
- Q17113918 wikiPageExternalLink www.molmed.com.
- Q17113918 wikiPageExternalLink financial-reports?language=en.
- Q17113918 wikiPageWikiLink Q1077603.
- Q17113918 wikiPageWikiLink Q140686.
- Q17113918 wikiPageWikiLink Q1417245.
- Q17113918 wikiPageWikiLink Q1592110.
- Q17113918 wikiPageWikiLink Q17143177.
- Q17113918 wikiPageWikiLink Q17637123.
- Q17113918 wikiPageWikiLink Q212646.
- Q17113918 wikiPageWikiLink Q3551506.
- Q17113918 wikiPageWikiLink Q3679953.
- Q17113918 wikiPageWikiLink Q38.
- Q17113918 wikiPageWikiLink Q484876.
- Q17113918 wikiPageWikiLink Q490.
- Q17113918 wikiPageWikiLink Q6353443.
- Q17113918 wikiPageWikiLink Q7108.
- Q17113918 wikiPageWikiLink Q891723.
- Q17113918 foundation "1996".
- Q17113918 industry Q7108.
- Q17113918 keyPeople Q3679953.
- Q17113918 keyPeople "(and CEO)".
- Q17113918 location Q38.
- Q17113918 location Q490.
- Q17113918 name "MolMed SpA".
- Q17113918 numEmployees "1202013".
- Q17113918 operatingIncome "€ 18.169 2013".
- Q17113918 products Q17143177.
- Q17113918 products Q17637123.
- Q17113918 revenue "€ 6.714 2013".
- Q17113918 type Q891723.
- Q17113918 type Organization.
- Q17113918 type Agent.
- Q17113918 type Company.
- Q17113918 type Organisation.
- Q17113918 type Agent.
- Q17113918 type SocialPerson.
- Q17113918 type Thing.
- Q17113918 type Q43229.
- Q17113918 comment "MOLMED is a medical biotechnology company located in Milan, inside the San Raffaele Biomedical Science Park(which houses the San Raffaele research hospital and Scientific Institute, and a private university).".
- Q17113918 label "MolMed".
- Q17113918 homepage www.molmed.com.
- Q17113918 homepage financial-reports?language=en.
- Q17113918 name "MolMed SpA".